BIOJAPAN is the longest-running international event about biotechnology in Japan. Last year, more than 350 companies attended the event and gathered 20,000 visitors from 15 countries.
BIOJAPAN 2007 is an opportunity for biotech companies to make valuable appointments with representatives among key players in this industry. This event is built on an exhibition, a conference program and partnering meetings, which make it possible to reach worthy international companies for open innovations and international collaboration.
As part of BIOJAPAN 2007, the French national pavilion organised by UBIFRANCE and the French Economic and Trade Commission in Japan will showcase the best of French bio industry technology.
The French national pavilion, which will be managed by UBIFRANCE, will host 25 French participants. In addition to major groups and 6 biotech competitiveness cluster, France's participation will also showcase several dynamic and innovative small and medium-sized companies. The French pavilion will be located at stand B1-10.
The French Biotechnology seminar, scheduled on September 20th during BIOJAPAN 2007, will address Japanese representatives in order to present French's cluster, technologies and Know how.
Exhibitors at Bio Japan 2007
ALIX
Bioparc - Bd Sébastien Brant
Parc d'Innovation
67400 ILLKIRCH - FRANCE Phone : +33 368 240 018 Fax : +33 368 240 016 Web Site : alix-pharma.fr
"AliX is an
early-stage drug discovery company founded 2002 as a spin-off from
the Department of Structural Biology and Genomics of IGBMC (Institute
of Genetics and Molecular and Cellular Biology) in Illkirch, France.
AliX has several R&D projects in structure-based design of drug candidates,
with a primary focus on nuclear hormone receptors. AliX also offers
service activity in protein and protein-ligand complex crystallization
and crystallographic structure determination, in structure-based
ligand design and hit-to-lead optimization, and in ligand screening
using non-denaturing mass spectrometry. AliX has developed a proprietary
approach for structure-based drug discovery combining X-ray crystallography
and mass spectrometry. We routinely use non-denaturing electrospray
ionization mass spectrometry to screen ligands for binding to given
targets. This is especially interesting when a functional assay is
not available, as in the case of orphan nuclear receptors. We have
now extended this approach to fragment-based drug discovery.
ATLANCHIM
2 rue de la Houssinière
BP 92208
44322 Nantes Cedex 3 - FRANCE Phone : +33 251 125 775 Fax : +33 251 125 770 Web Site : www.atlanchim.com
"Founded in January 2004, AtlanChim is an innovative French laboratory,
providing a well-recognized expertise in fine organic chemistry
(mg to kg scale) via contract manufacturing for leading R&D centers:
pharmaceuticals, cosmetics, biotechs, diagnostics, agrochemicals,
health foods, reagents, electronics, institutes and universities:
- Research assistance
- Reproduction synthesis
- Site-specific stable isotope labeling
- Spin-labeling
Aim: Giving priority to Client relations to ensure we are a reliable
partner working hand in hand with your research laboratories. We
supply custom-made multi-step synthesis to serve each Client's
specific needs. All goods are manufactured to the design and specifications
of the Purchasers. In order to extend AtlanChim's services to Japanese
and Asian Customers, the first subsidiary was founded in May 2006
(Bronze Prize Award, September 2006, Osaka City).
Ethics: Assuring our Clients reach their objectives
- Project Manager (PhD) assigned to your order
- Confidentiality, flexibility and reactivity
- Quality commitment (ISO 9001/2000)
- Company charter
Phone : +33 390 403 000 Fax : +33 390 403 001 Web Site : www.biovalley.com
Alsace BioValley
is one of the top three BioClusters in Europe, assembling both world
class public research and training with industry leaders in Pharma
and Biotech. Our cluster organization offers a wide range of services
and financial incentives to help foreign companies either develop
partnerships with BioValley players, or explore the advantages of
creating activities in Alsace to cover parts of European markets.
Phone : +33 388 247 768 Fax : +33 388 247 777 Web Site : www.alsace.international.eu
French company
specialized in biotechnologies
CANCERBIO
SANTE
9 Immeuble Alfonse Jourdain
place Alfonse Jourdain
31000 TOULOUSE - FRANCE Phone : +33 534 255 040 Fax : +33 534 255 041 Web Site : www.cancerbiosante.fr
The Cancer-Bio-Health
Competitiveness Cluster which was approved by the French Government
in July, 2005 groups the principal actors in the Midi-Pyrénees and
Limousin regions involved in the fight against cancer.
the Cancer-Bio-Health cluster has a dual objective, which is both to
favour therapeutic innovations to the benefit of patients and to create
wealth (companies, partnerships, intellectual property, innovation)
and employment.
The Cancer-Bio-Health cluster can also depend on the strengths of the
Midi-Pyrénées and Limousin regions, which are pharmaceutical, agrifood
and biotechnology sectors.
In total, the Cancer-Bio-Health cluster represents more than 20,000
private-sector jobs, 10,000 of them in industrial R&D, to which
should be added nearly 9000 people working in public sector research.
The dedicated and integrated Cancéropôle of Toulouse-Langlade will
be the core campus of the competitiveness cluster which also draws
resources from industrial players throughout the region, ranging from
major drug companies to SME or start-ups."
CANCEROPOLE
ILE DE FRANCE 1 Hopital Saint-Louis
av Claude Vellefaux 75010 PARIS - FRANCE
Phone : +33 148 037 240 Fax : +33 142 392 165 Web Site : www.canceropole-idf.com
French company
specialized in biotechnologies
CELLECTIS 102 Route de Noisy
93235 Romainville Cedex - FRANCE
Phone : +33 141 839 900 Fax : +33 141 839 903 Web Site : www.cellectis.com
CELLECTIS is
the world leader in applying the technology of Meganuclease Recombination
Systems to in vivo genome engineering and genome surgery. The company
is focused on the research and development of custom-Meganuclease
Recombination Systems for in vivo DNA interventions and also provides
new tools for rational genome engineering and targeted recombination
in living cells. CELLECTIS develops recombination systems based on
a novel class of genetic scissors: the Meganucleases. The technological
breakthrough is the Meganuclease Recombination Systems (MRS) based
on the Homologous Recombination and the Meganucleases. Cellectis'
technology allow to perform precise modifications on chromosomes
such as deletions, insertions or substitutions of genomic sequences.
We design the meganuclease to target sequences of interest in the
genome in vivo or ex vivo. CELLECTIS products are patented proprietary
technologies. Applications of Meganuclease Recombination Systems
(MRS)cover human genome therapy (somatic, stem cells and anti-viral),
animal models, protein production and bioprocessed molecules or genetic
improvement of plant or animal species.
DBV
TECHNOLOGIES
88, avenue Leclerc
92100 Boulogne Billancourt - FRANCE
Phone : +33 155 389 270 Fax : +33 141 312 882 Web Site : www.dbv-technologies.com
DBV has created
E-patch® technology for cutaneous administration of active ingredients
and is using it in the development of product ranges for diagnosis
and treatment. DBV Technologies developed a way of delivery for larger
and more fragile drug molecules to pass into the skin, opening the
possibilities for controlled, pain-free delivery of virtually any
drug or vaccine. The E-patch technology allows to a cost-effective
and easy to use skin patch, holding the dry drug by electrostatic
forces by passing cold chain constraints. The occlusion created on
the skin facilitates the flow of non-denatured proteins, peptides,
and other molecules into the body without the use of needles.
Phone : +33 145 688 407 Fax : +33 145 688 657 Web Site : www.genomicvision.com
GENOMIC VISION
develops novel diagnostic and drug discovery solutions based on its
world-leading nanotechnology for DNA analysis in the areas of cancer
and acute diseases.
Phone : +33 153 105 340 Fax : +33 153 105 311 Web Site : www.heliosbiosciences.com
To accurately
characterize therapeutic targets HELIOS BIOSCIENCES brings a new
paradigm in systems biology by introducing the dynamic dimension
in the study of biological regulatory pathways. We build directed
networks of intermolecular interactions and develop software to model
the dynamics of these network’s responses after pathological / pharmacological
stimuli. The company offers access to its molecular interaction networks
and the opportunity to co-develop dynamic models of these networks.
1. Algorithmes and Sotwares to Modelize and Predict the evolution
of molecular networks during physio-pathological processus. 2. Because
no networks of interactions are accurate enough to sustain the development
of our dynamic system biology approach, we have developped an outsatnding
know-how and expertise in building networks of molecular interactions.
3. Technologies to characterize the expression of genes in tissue
sections.
INSTITUT
PASTEUR
Office of Technology Transfer 28 rue du Dr. Roux
75724 PARIS Cedex 15 - FRANCE
Phone : +33 145 688 939 Fax : +33 140 613 732 Web Site : www.pasteur.fr
Research Institute
Mission: Private Institute Dedicated to Research and Public Health
Business Strategy : Licensing technologies, patented by the Institute
Pasteur, to the Industry. Infectious diseases, Molecular Biology,
Genomics, Proteomics, Genetic Disorders, Cancer, Immunology, Immunopathology,
Neurobiology, Neuropathology, Parasitology.
INVEST LANGUEDOC ROUSSILLON
417, rue Samuel Morse
Le Millénaire II
34000 Montpellier - FRANCE
Phone : +33 467 229 480
LYONBIOADVISOR
Aderly, place de la Bourse
69289 Lyon - FRANCE
Phone : +33 472 405 632 Fax : +33 472 405 735 Web Site : www.lyonbioadvisor.com
Lyon BioAdvisor
is the first customized service providing a pilot dedicated to ensure
the success of your partnership projects. Encompassing 66 000 jobs
in life science, Lyon BioAdvisor speeds up your access to expertise,
activates its network and mobilizes all the resources you need. Aiming
to promote Lyon as one of the top 5 European bio clusters especially
in the fields of viro immunology/vaccine and cancer, it has developed
an extensive package of supports for inward investments, creation,
development of biotech companies, dedicated premises and international
events (Biovision, Biosquare).
LYON BIOPOLE
17 rue bourgelat
69002 Lyon - FRANCE
Phone : +33 472 407 972 Fax : +33 472 407 950 Web Site : www.lyonbiopole.org
"Lyonbiopole
aims to manage human and animal infectious disease in a global approach
in order to meet public healthcare needs by:
- Building a ""healthcare shield"" to fight human
and animal infectious diseases and viral-induced cancers developing
innovative diagnostic, preventive and therapeutic solutions and delivery
systems for more responsive, personalized medicine.
2 Main programs: Diagnostic and vaccines/ New therapies thematics:
Host-pathogen interaction/ infection mechanism, immunology, epidemiology/
emerging disease, chronic infection/ Cancer/ pathogen induced cancer,
vaccine, diagnostics and analytical methods
26 multipartners R&D projects fostered (60 MEuros investment/ 16
MEuros granted public funding) with Merial, Sanofi Pasteur, Biomerieux,
BD, International Cancer Research Centre (WHO), University Hospitals.
"
NMRTEC Bioparc - Bd Sébastien Brant
67400 ILLKIRCH - FRANCE
Phone : +33 368 240 060 Fax : +33 368 240 069 Web Site : www.nmrtec.com
NMRtec aims
to help all organizations - engaged in material analysis, research
and development, including universities, biotech, and government
laboratories - make decisive improvements in their analytical management
and performance. NMRtec provides high quality analyses using leading
edge Solution and Solid States NMR techniques.
Novalyst is
a private company and contract research organization with strong
expertise in organic synthesis and proprietary technologies.
Our service offering includes R&D support as well as specific synthesis
services or custom synthesis from mg to subkilogram scale.
Our proprietary technologies provide alternative approaches for synthetic
pathways exploration and fast chemistry development.
We increase our partner R&D productivity offering cost-effective
chemistry outsourcing solutions.
NOVASEP
Boulevard de la Moselle
BP50 54340 Pompey - FRANCE
Phone : +33 383 497 130 Fax : +33 383 497 140 Web Site : www.novasep-japan.com
"Groupe
Novasep, with its headquarters near Nancy (in eastern France), works
with the pharmaceutical, food, cosmetics, agrochemicals, and specialty
chemicals industries through its two business segments: Novasep Process
and Novasep Synthesis. Both strategic businesses are complementary
organisations with skills designed to provide technically optimised
and economical solutions for the life-science sector and related
industries.
Novasep Process specialises in solving purification challenges for
the Pharmaceutical, Biopharmaceutical and Industrial Biotech markets.
The company offers laboratory purification equipment as well as large-scale
industrial production plants for producing pure products, and a full
range of services including process development, multi-ton scale custom
purification and performance optimisation.
Novasep Synthesis provides R&D and custom synthesis, from lab to
industrial scale, with special expertise in hazardous chemistry , chiral
chemistry, early stage services and highly potent APIs. It includes
Dynamit Nobel, Finorga and Seripharm.
Phone : +33 328 559 060 Fax : +33 328 559 061 Web Site : www.pole-nsl.org
Obesity, diabetes,
hypertension Alzheimer's and Parkinson's diseases, the metabolic
diseases linked to ageing, unhealthy diet and today’s ever-increasing
sedentary lifestyle require suitable responses. This is the challenge
taken on by the NHL Cluster.
Innovation is the key word with a real response to the needs in terms
of the treatment and the prevention of cardiovascular, metabolic and
age-related pathologies to be found in molecules, food ingredients
and medical devices.
In 2006, about thirty projects were approved by the Cluster, for a
total R&D budget amounting to over 37 million EUR. These projects,
defined and initiated by the 39 members of the Biohealth, Agrifood
and Biotechnology Sectors of the Cluster thus confirm the R&D private
and academic collaboration dynamic. At least 25 to 30 new projects
will be approved each year.
Main actors: Bonduelle, Finaler, Lesaffre Mac Cain, Roquette, Cellial
Technologies, Genfit, Macopharma, Regional University Hospital Centre
of Lille, University of Lille I, II and III, most of the regional laboratories
of INSERM and CNRS, Pasteur Institute of Lille…
OROXCELL
Overall Managment Parc Biocitech 102, route de Noisy
93230 ROMAINVILLE - France - FRANCE
Phone : +33 141 837 220 Fax : +33 141 837 227 Web Site : http://www.oroxcell.com
French CRO
focused on bioavailability, pharmacokinetics and biopharmaceutical
discovery. ADME: Caco-2, P-gp interaction, metabolic stability (S9,
microsomes, hepatocytes), Cyp inhibition, induction, pKa in rodents,
tissue distribution Physico-chemistry: Log P, Log D, pKa, stability
Bioanalysis: LCMS, LCMSMS, LCUV, radioactivity.
ORPHEME
2 rue Henri Barbusse
13001 MARSEILLE - FRANCE
Phone : +33 499 776 465 Fax : +33 499 776 892 Web Site : www.orpheme.org
"ORPHEME
is a health competitiveness cluster dealing with orphan diseases
and emerging pathologies.
ORPHEME is gathering 2 regional councils (Languedoc Roussillon and
Provence Alpes Cote d'Azur) and 5 cities: Montpellier, Nimes, Marseille,
Toulon and Nice.
They are 4 themes:
- Diagnosis & treatment of infectious & tropical diseases
- Medical equipment & Bio-engineering
- Treatment & care of ageing, neurological diseases and handicap
- Diagnosis & Immunotherapy of rare and emerging cancers"
SEPTIMANIE EXPORT
L’Acropole
954 avenue Jean Mermoz
34000 Montpellier - FRANCE
Phone : +33 499 642 929 Fax : +33 499 642 937 Web Site : www.passeport-export.com
Active business
partner in the Languedoc-Roussillon Region. The Languedoc-Roussillon
Region, through Septimanie Export, accompanies the Biocluster of "Sud
de France" into national and international markets, allowing
them to come together under a common image and to reinforce their
commercial approach.
VECTALYS
Prologue Biotech - rue Pierre et Marie Curie
BP 28262
31682 LABEGE - FRANCE Phone : +33 562 710 508 Fax : +33 561 287 075 Web Site : www.vectalys.com
Active business
partner in the Languedoc-Roussillon Region. The Languedoc-Roussillon
Region, through Septimanie Export, accompanies the Biocluster of "Sud
de France" into national and international markets, allowing
them to come together under a common image and to reinforce their
commercial approach.
